eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
other↓, other↝, Hcy/homoC↓, eff↝, other↝,
eff↝, CardioT↝, ROS↝, ROS↝, ROS↓,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
TumCD↑, ChemoSen↑, BAX↑, Apoptosis↑, CSCs↓, ROS↑, eff↝, JNK↑, p38↑, NF-kB↓,
| - |
in-vivo, |
PC, |
Panc02 |
|
|
|
- |
in-vivo, |
BC, |
4T1 |
|
|
|
CellMemb↑, Ca+2↑, DNAdam↑, eff↝, Imm↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
eff↝, TumCP↓, TumCP∅, MAPK↑, Bax:Bcl2↑, Apoptosis↑,
| - |
in-vitro, |
Lung, |
H157 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Colon, |
HCT15 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
TrxR↓, selectivity↑, eff↑, eff↝, ROS↑, MMP↓, Apoptosis↑, eff↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
TumCP↓, MMP↓, ROS↑, eff↝, selectivity↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vivo, |
Nor, |
MCF10 |
|
|
|
Ca+2↑, Apoptosis↑, eff↝, eff↑, selectivity↑, eff↝, eff↝,
Dose↑, CellMemb↑, eff↝, other↝, TumCG↓,
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
OS↑, e-pH↑, TumMeta↓, eff↝, TumCG↝,
DNMTs↓, eff↑, eff↝,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
eff↝, TumCCA↑, TumCMig↓, ROS↑, BAX↑, Mst1↑, Bcl-2↓, YAP/TEAD↓, LATS1↓,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
TumCP↓, Apoptosis↑, UHRF1↓, DNMT1↓, HDAC1↓, eff↝,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
LATS1↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 1, ROS↑, 4, ROS↝, 2, TrxR↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 2,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 5, BAX↑, 2, Bax:Bcl2↑, 1, Bcl-2↓, 1, JNK↑, 1, MAPK↑, 1, p38↑, 1, TumCD↑, 1, YAP/TEAD↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↓, 1, other↝, 3,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, DNMT1↓, 1, DNMTs↓, 1, UHRF1↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, HDAC1↓, 1, Mst1↑, 1, TumCG↓, 1, TumCG↝, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 2, TumCMig↓, 1, TumCP↓, 3, TumCP∅, 1, TumMeta↓, 1,
Barriers & Transport(tgid=15) ⓘ
CellMemb↑, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Imm↑, 1, NF-kB↓, 1,
Cellular Microenvironment(tgid=17) ⓘ
e-pH↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↑, 1, eff↑, 4, eff↝, 15, selectivity↑, 3,
Clinical Biomarkers(tgid=22) ⓘ
Hcy/homoC↓, 1,
Functional Outcomes(tgid=23) ⓘ
CardioT↝, 1, OS↑, 1,
Total Targets: 44
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:961 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page